BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Kidney, Nosology, Cisplatin, rs4950928, PBX1, cell-cell adhesion, Leukemia)
Bookmark Forward

QuickView for osi 774 (compound)


Genetic Markers

Most Correlated Genes

Loading...
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

Loading...
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

No studies found
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Solid amorphous formulations for enhancing solubility and inhibiting Erlotinib crystallization durin…
  2. PEGylated Erlotinib HCl Injectable Nanoformulation for Improved Bioavailability.
  3. Electrochemical and theoretical study on interaction between erlotinib and DNA.
  4. Development and validation of HPLC method for simultaneous estimation of erlotinib and niclosamide f…
  5. Xijiao Dihuang decoction relieves the erlotinib-induced dermatitis.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Study of OSI-774 (Tarceva) in Previously Untreated Elderly Lung Cancer Patients
  2. Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung Cancer
  3. Single-agent Erlotinib in Patients Previously Treated With Oral Etoposide in Protocol OSI-774-205
  4. Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid Carcinoma
  5. Secondary Primary Tumor Prevention With EGFR, OSI-774, and Cyclooxygenase-2
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.